Hanne Christensen, MD, PhD, MSci, University of Copenhagen, Copenhagen, Denmark, discusses the evolution in the understanding and treatment of transient ischaemic attacks (TIAs) over the past two decades. Previously, TIAs were often dismissed as harmless, and patients were sent home without intervention. However, the perception has shifted, and now TIAs are recognized as high-risk situations. Patients are now admitted or seen in urgent outpatient departments to enable the immediate initiation of secondary prevention measures. Prof. Christensen highlights the importance of initiating treatment as soon as possible, as studies have shown that the risk of a new event, such as a TIA or a stroke, is highest within the first 24 hours to seven days. This new understanding has led to a dramatic change in attitude and treatment towards TIAs. This interview took place at the European Academy of Neurology (EAN) 2023 Congress in Budapest, Hungary.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.